1,8-naphthalimide imidazo(4,5,1-de)acridones with anti-tumor activity

Details for Australian Patent Application No. 2001240054 (hide)

Owner The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Michejda, Christopher J.; Kosakowska-Cholody, Teresa; Cholody, Wieslaw M

Agent Spruson & Ferguson

Pub. Number AU-B-2001240054

PCT Pub. Number WO01/66545

Priority 60187991 07.03.00 US

Filing date 5 March 2001

Wipo publication date 17 September 2001

Acceptance publication date 11 August 2005

International Classifications

C07D 471/06 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61P 035/00 Antineoplastic agents

A61K 031/437

C07D 221/00 Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 235/00 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

11 August 2005 Application Accepted

  Published as AU-B-2001240054

8 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001240055

2001240053-Idler pulley